Disruption of inhibitory G-proteins mediates a reduction in atrial β-adrenergic signaling by enhancing eNOS expression

Cardiovascular Research

Volumn 67, Issue 4, 2005, Pages 613-623

  Danson, E J F ^a   Zhang, Y H ^b   Sears, C E ^b   Edwards, A R ^b   Casadei, B ^b   Paterson, D J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Acetylcholine; Calcium; Catecholamines; Contractility; Nitric oxide synthase

Indexed keywords

BETA ADRENERGIC RECEPTOR; CALCIUM ION; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; MUSCARINIC RECEPTOR BLOCKING AGENT; NITRIC OXIDE; PERTUSSIS TOXIN; PROTEIN; SODIUM CHLORIDE;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CALCIUM CELL LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME INHIBITION; HEART ATRIUM; HEART ATRIUM FUNCTION; HEART CONTRACTION; HEART MUSCLE CELL; HEART RATE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADRENERGIC BETA-AGONISTS; ANIMALS; BLOTTING, WESTERN; CALCIUM; CALCIUM CHANNELS; CAVEOLIN 3; GENE EXPRESSION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HEART ATRIA; IMMUNOHISTOCHEMISTRY; ISOPROTERENOL; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PATCH-CLAMP TECHNIQUES; PERTUSSIS TOXIN; SIGNAL TRANSDUCTION;

EID: 22744436073     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.04.034     Document Type: Conference Paper

References (50)

1. J.N. Cohn, T.B. Levine, M.T. Olivari, V. Garberg, D. Lura, and G.S. Francis Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 1984 819 823
2. R.E. Kleiger, J.P. Miller, J.T. Bigger Jr., and A.J. Moss Decreased heart rate variability and its association with increased mortality after acute myocardial infarction Am J Cardiol 59 1987 256 262
3. M.T. La Rovere, J.T. Bigger Jr., F.I. Marcus, A. Mortara, and P.J. Schwartz Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators Lancet 351 1998 478 484
4. J. Nolan, P.D. Batin, R. Andrews, S.J. Lindsay, P. Brooksby, and M. Mullen Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart) Circulation 98 1998 1510 1516
5. M. Li, C. Zheng, T. Sato, T. Kawada, M. Sugimachi, and K. Sunagawa Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats Circulation 109 2004 120 124
6. T.E. Mertz, and H.R. Kaplan Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats J Pharmacol Exp Ther 223 1982 580 586
7. H. Takahashi, K. Maehara, N. Onuki, T. Saito, and Y. Maruyama Decreased contractility of the left ventricle is induced by the neurotransmitter acetylcholine, but not by vagal stimulation in rats Jpn Heart J 44 2003 257 270
8. S. Bibevski, and ME. Dunlap Ganglionic mechanisms contribute to diminished vagal control in heart failure Circulation 99 1999 2958 2963
9. P.B. Massion, O. Feron, C. Dessy, and J.L. Ballig Nitric oxide and cardiac function: ten years after, and continuing Circ Res 93 2003 388 398
10. R. Gyurko, P. Kuhlencordt, M.C. Fishman, and P.L. Huang Modulation of mouse cardiac function in vivo by eNOS and ANP Am J Physiol, Heart Circ Physiol 278 2000 H971 H981
11. A. Godecke, T. Heinicke, A. Kamkin, I. Kiseleva, R.H. Strasser, and U.K. Decking Inotropic response to beta-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts J Physiol 532 2001 195 204
12. L.A. Barouch, R.W. Harrison, M.W. Skaf, G.O. Rosas, T.P. Cappola, and Z.A. Kobeissi Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms Nature 416 2002 337 339
13. J.L. Balligand, and P.J. Cannon Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences Arterioscler Thromb Vasc Biol 17 1997 1846 1858
14. X. Han, I. Kubota, O. Feron, D.J. Opel, M.A. Arstall, and Y.Y. Zhao Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase Proc Natl Acad Sci U S A 95 1998 6510 6515
15. G. Vandecasteele, T. Eschenhagen, H. Scholz, B. Stein, I. Verde, and R. Fischmeister Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase Nat Med 5 1999 331 334
16. P.B. Massionm, C. Dessy, F. Desjardins, M. Pelat, X. Havaux, and C. Belge Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction Circulation 110 2004 2666 2672
17. H.C. Champion, D. Georgakopoulos, E. Takimoto, T. Isoda, Y. Wang, and D.A. Kass Modulation of in vivo cardiac function by myocyte-specific nitric oxide synthase-3 Circ Res 94 2004 657 663
18. F.H. Khadour, D.W. O'Brien, Y. Fu, P.W. Armstrong, and R. Schulz Endothelial nitric oxide synthase increases in left atria of dogs with pacing-induced heart failure Am J Physiol 275 1998 H1971 H1978
19. M. Fukuchi, S.N. Hussain, and A. Giad Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion site and beta-adrenergic receptor therapy Circulation 98 1998 132 139
20. K. Imai, H. Sato, M. Hori, H. Kusuoka, H. Ozaki, and H. Yokoyama Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure J Am Coll Cardiol 24 1994 1529 1535
21. J.M. Hare, B. Kim, N.A. Flavahan, K.M. Ricker, X. Peng, and L. Colaman Pertussis toxin-sensitive G proteins influence nitric oxide synthase III activity and protein levels in rat heart J Clin Invest 101 1998 1424 1431
22. F. Brunner, P. Andrew, G. Wolkart, R. Zechner, and B. Mayer Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase Circulation 104 2001 3097 3102
23. D.E. Vatner, N. Sato, J.B. Galper, and S.F. Vatner Physiological and biochemical evidence for coordinate increases in muscarinic receptors and Gi during pacing-induced heart failure Circulation 94 1996 102 107
24. E.J. Danson, and D.J. Paterson Enhanced neuronal nitric oxide synthase expression is central to cardiac vagal phenotype in exercise-trained mice J Physiol 546 2003 225 232
25. J.K. Choate, E.J. Danson, J.F. Morris, and D.J. Paterson Peripheral vagal control of heart rate is impaired in neuronal NOS knockout mice Am J Physiol Heart Circ Physiol 280 2001 H2310 H2317
26. 2+ current is not altered in cardiac ventricular myocytes from mice lacking endothelial nitric oxide synthase J Physiol 528 2000 279 289
27. B. Casadei, and C.E. Sears Nitric-oxide-mediated regulation of cardiac contractility and stretch responses Prog Biophys Mol Biol 82 2003 67 80
28. B. Stein, T. Eschenhagen, J. Rudiger, H. Scholz, U. Forstermann, and I. Gath Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure J Am Coll Cardiol 32 1998 1179 1186
29. I. Fleming, and R. Busse Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase Am J Physiol Regul, Integr Comp Physiol 284 2003 R1 R12
30. U. Laufs, and J.K. Liao Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase J Biol Chem 273 1998 24266 24271
31. L. Belhassen, R.A. Kelly, T.W. Smith, and J.L. Balligand Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcription in vitro and in vivo by cyclic adenosine monophosphate in rat cardiac myocytes J Clin Invest 97 1996 1908 19015
32. O. Feron, T.W. Smith, T. Michel, and R.A. Kelly Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes J Biol Chem 272 1997 17744 17748
33. O. Feron, C. Dessy, D.J. Opel, and T. Michael Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate J Biol Chem 273 1998 30249 30254
34. J.M. Hare, R.A. Lofthouse, G.J. Juang, L. Colman, K.M. Ricker, and B. Kim Contribution of caveolin protein abundance to augmented nitric oxide signaling in conscious dogs with pacing-induced heart failure Circ Res 86 2000 1085 1092
35. J.K. Bendall, T. Damy, P. Ratajczak, X. Loyer, V. Monceau, and I. Marty Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat Circulation 110 2004 2368 2375
36. T. Rankinen, T. Rice, L. Perusse, Y.C. Chagnon, J. Gagnon, and A.S. Leon NOS3 Glu298Asp genotype and blood pressure response to endurance training: the HERITAGE family study Hypertension 36 2000 885 889
37. M. Federici, A. Pandolfi, E.A. De Filippis, G. Pellegrini, R. Menghini, and D. Lauro G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells Circulation 109 2004 399 405
38. G.P. Rossi, M. Cesari, M. Zanchetta, S. Colonna, G. Maiolino, and L. Pedon The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study J Am Coll Cardiol 41 2003 930 937
39. A.M. Shah, A. Mebazaa, R.C. Wetzel, and E.G. Lakatta Novel cardiac myofilament desensitizing factor released by endocardial and vascular endothelial cells Circulation 89 1994 2492 2497
40. L. Gorza, S. Sartore, L.E. Thornell, and S. Schiaffino Myosin types and fiber types in cardiac muscle: III. Nodal conduction tissue J Cell Biol 102 1986 1758 1766
41. W. Schulze, A. Kossler, K.D. Hinsch, W. Rosenthal, L. Will-Shahab, and I. Kuttner Immunocytochemical localization of G-proteins (alpha subunits) in rat heart tissue Eur Heart J 12 Suppl F 1991 132 134
42. J.D. Kilts, M.A. Gerhardt, M.D. Richardson, G. Sreeram, G.B. Mackensen, and H.P. Grocott Beta(2)-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both G(s) and G(i) Circ Res 87 2000 705 709
43. J. Oostendorp, and A.J. Kaumann Pertussis toxin suppresses carbachol-evoked cardiodepression but does not modify cardiostimulation mediated through beta1- and putative beta4-adrenoceptors in mouse left atria: no evidence for beta2- and beta3-adrenoreceptor function Naunyn-Schmiedeberg's Arch Pharmacol 361 2000 134 145
44. D.L. Campbell, J.S. Stamler, and H.C. Strauss Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols J Gen Physiol 108 1996 277 293
45. T.M. Lincoln, and J.D. Corbin Purified cyclic GMP-dependent protein kinase catalyzes the phosphorylation of cardiac troponin inhibitory subunit (TN-1) J Biol Chem 253 1978 337 339
46. A. Zahradnikova, I. Minarovic, R.C. Venema, and L.G. Meszaros Inactivation of the cardiac ryanodine receptor calcium release channel by nitric oxide Cell Calcium 22 1997 447 454
47. 2+ release in cardiomyocytes Nat Cell Biol 3 2001 867 873
48. M.T. Ziolo, H. Katoh, and D.M. Bers Positive and negative effects of nitric oxide on Ca(2+) sparks: influence of beta-adrenergic stimulation Am J Physiol Heart Circ Physiol 281 2001 H2295 H2303
49. M.G. Petroff, A. Younes, J. Egan, E.G. Lakatta, and S.J. Sollott Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes Circ Res 84 1999 1020 1031
50. M.E. Lewis, A.H. Al-Khalidi, R.S. Bonser, T. Clutton-Brock, D. Morton, and D. Paterson Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart J Physiol 534 2001 547 552